{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T21:14:52Z","timestamp":1767993292778,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12916-015-0445-x","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T13:02:22Z","timestamp":1441371742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data"],"prefix":"10.1186","volume":"13","author":[{"name":"WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group","sequence":"first","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,9,7]]},"reference":[{"key":"445_CR1","doi-asserted-by":"crossref","DOI":"10.30875\/9f925144-en","volume-title":"World malaria report 2014","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). World malaria report 2014. Geneva: WHO; 2014."},{"key":"445_CR2","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/S0140-6736(13)62566-0","volume":"383","author":"AM Noor","year":"2014","unstructured":"Noor AM, Kinyoki DK, Mundia CW, Kabaria CW, Mutua JW, Alegana VA, et al. The changing risk of Plasmodium falciparum malaria infection in Africa: 2000\u201310: a spatial and temporal analysis of transmission intensity. Lancet. 2014;383:1739\u201347.","journal-title":"Lancet."},{"key":"445_CR3","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med."},{"key":"445_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med."},{"key":"445_CR5","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, Mc Gready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet."},{"key":"445_CR6","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/AAC.00686-12","volume":"57","author":"R Leang","year":"2013","unstructured":"Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, et al. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother. 2013;57:818\u201326.","journal-title":"Antimicrob Agents Chemother."},{"key":"445_CR7","doi-asserted-by":"publisher","first-page":"e57689","DOI":"10.1371\/journal.pone.0057689","volume":"8","author":"MP Kyaw","year":"2013","unstructured":"Kyaw MP, Nyunt MH, Chit K, Aye MM, Aye KH, Lindegardh N, et al. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. PLoS One. 2013;8:e57689.","journal-title":"PLoS One."},{"key":"445_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med."},{"key":"445_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"5","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;5:415\u201321.","journal-title":"Lancet Infect Dis."},{"key":"445_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/1475-2875-10-339","volume":"10","author":"JA Flegg","year":"2011","unstructured":"Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.","journal-title":"Malar J."},{"key":"445_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/1475-2875-10-278","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. The parasite clearance curve. Malar J. 2011;10:278.","journal-title":"Malar J."},{"key":"445_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1186\/1475-2875-12-411","volume":"12","author":"JA Flegg","year":"2013","unstructured":"Flegg JA, Gu\u00e9rin PJ, Nosten F, Ashley EA, Phyo AP, Dondorp AM, et al. Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives. Malar J. 2013;12:411.","journal-title":"Malar J."},{"key":"445_CR13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature."},{"key":"445_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2014","unstructured":"Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. J Infect Dis. 2014;211:670\u20139.","journal-title":"J Infect Dis."},{"key":"445_CR15","doi-asserted-by":"crossref","unstructured":"Conrad MD, Bigira V, Kapisi J, Muhindo M, Kamya MR, Havlir DV, et al. Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children. PLoS One. 2014;9.","DOI":"10.1371\/journal.pone.0105690"},{"key":"445_CR16","first-page":"1352","volume":"211","author":"E Kamau","year":"2014","unstructured":"Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2014;211:1352\u20135.","journal-title":"J Infect Dis."},{"key":"445_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","volume":"211","author":"SM Taylor","year":"2014","unstructured":"Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2014;211:680\u20138.","journal-title":"J Infect Dis."},{"key":"445_CR18","unstructured":"WorldWide Antimalarial Resistance Network (WWARN). Tracking resistance. [ http:\/\/www.wwarn.org\/tracking-resistance\/ ]"},{"key":"445_CR19","volume-title":"Status report on artemisinin resistance","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO). Status report on artemisinin resistance. Geneva: WHO; 2014 [ http:\/\/www.who.int\/malaria\/publications\/atoz\/status_rep_artemisinin_resistance_sep2014.pdf?ua=1 ]"},{"key":"445_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1086\/650301","volume":"201","author":"K Stepniewska","year":"2010","unstructured":"Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, et al. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis. 2010;201:570\u20139.","journal-title":"J Infect Dis."},{"key":"445_CR21","unstructured":"WorldWide Antimalarial Resistance Network (WWARN) Parasite Clearance Study Group. Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis. Malaria Journal. 2015; In Press."},{"key":"445_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4269\/ajtmh.2012.12-0058","volume":"87","author":"AW Maiga","year":"2012","unstructured":"Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, et al. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg. 2012;87:23\u20138.","journal-title":"Am J Trop Med Hyg."},{"key":"445_CR23","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/infdis\/jit082","volume":"207","author":"TM Lopera-Mesa","year":"2013","unstructured":"Lopera-Mesa TM, Doumbia S, Chiang S, Zeituni AE, Konate DS, Doumbouya M, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis. 2013;207:1655\u201363.","journal-title":"J Infect Dis."},{"key":"445_CR24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/infdis\/jiu427","volume":"211","author":"PA Ndour","year":"2014","unstructured":"Ndour PA, Lopera-Mesa TM, Diakit\u00e9 SAS, Chiang S, Mouri O, Roussel C, et al. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria. J Infect Dis. 2014;211:290\u20137.","journal-title":"J Infect Dis."},{"key":"445_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1475-2875-9-53","volume":"9","author":"A Sowunmi","year":"2010","unstructured":"Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, et al. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malar J. 2010;9:53.","journal-title":"Malar J."},{"key":"445_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1475-2875-12-125","volume":"12","author":"D Das","year":"2013","unstructured":"Das D, Price RN, Bethell D, Guerin PJ, Stepniewska K. Early parasitological response following artemisinin-containing regimens: a critical review of the literature. Malar J. 2013;12:125.","journal-title":"Malar J."},{"key":"445_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1475-2875-13-32","volume":"13","author":"MK Muhindo","year":"2014","unstructured":"Muhindo MK, Kakuru A, Jagannathan P, Talisuna A, Osilo E, Orukan F, et al. Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria. Malar J. 2014;13:32.","journal-title":"Malar J."},{"key":"445_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4269\/ajtmh.2012.12-0025","volume":"87","author":"RM Fairhurst","year":"2012","unstructured":"Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, et al. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. Am J Trop Med Hyg. 2012;87:231\u201341.","journal-title":"Am J Trop Med Hyg."},{"key":"445_CR29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1128\/AAC.41.7.1413","volume":"41","author":"NJ White","year":"1997","unstructured":"White NJ. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997;41:1413\u201322.","journal-title":"Antimicrob Agents Chemother."},{"key":"445_CR30","unstructured":"WorldWide Antimalarial Resistance Network (WWARN). WWARN Clinical Trials Publication Library: Methodology. [ http:\/\/www.wwarn.org\/tools-resources\/literature-reviews\/wwarn-clinical-trials-publication-library\/methodology ]"},{"key":"445_CR31","volume-title":"Clinical module: data management and statistical analysis plan. Version 1.2","author":"WorldWide Antimalarial Resistance Network (WWARN)","year":"2012","unstructured":"WorldWide Antimalarial Resistance Network (WWARN). Clinical module: data management and statistical analysis plan. Version 1.2. Oxford: WWARN; 2012."},{"key":"445_CR32","volume-title":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system","author":"World Health Organization (WHO)","year":"2011","unstructured":"World Health Organization (WHO). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. Geneva: WHO; 2011. [ http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf ]"},{"key":"445_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1475-2875-7-149","volume":"7","author":"SJ Lee","year":"2008","unstructured":"Lee SJ, Stepniewska K, Anstey N, Ashley E, Barnes K, Binh TQ, et al. The relationship between the haemoglobin concentration and the haematocrit in Plasmodium falciparum malaria. Malar J. 2008;7:149.","journal-title":"Malar J."},{"key":"445_CR34","volume-title":"Statistical analysis plan artemisinin combination therapy (ACT) in Africa baseline early parasitological response (EPF) individual patient pooled analysis Version 1","author":"WorldWide Antimalarial Resistance Network (WWARN)","year":"2012","unstructured":"WorldWide Antimalarial Resistance Network (WWARN). Statistical analysis plan artemisinin combination therapy (ACT) in Africa baseline early parasitological response (EPF) individual patient pooled analysis Version 1. Oxford: WWARN; 2012."},{"key":"445_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1475-2875-10-378","volume":"10","author":"PW Gething","year":"2011","unstructured":"Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10:378.","journal-title":"Malar J."},{"key":"445_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/0471445428","volume-title":"Statistical methods for rates and proportions","author":"J Fleiss","year":"2003","unstructured":"Fleiss J, Paik M, LB H. Statistical methods for rates and proportions. 3rd ed. Hoboken, NJ: John Wiley & Sons; 2003.","edition":"3"},{"key":"445_CR37","volume-title":"Multiple imputation for nonresponse in surveys","author":"R Db","year":"1987","unstructured":"Db R. Multiple imputation for nonresponse in surveys. Hoboken, NJ: John Wiley & Sons; 1987."},{"key":"445_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0035-9203(99)90325-5","volume":"93","author":"T Smith","year":"1999","unstructured":"Smith T, Felger I, Kitua A, Tanner M, Beck HP. Dynamics of multiple Plasmodium falciparum infections in infants in a highly endemic area of Tanzania. Trans R Soc Trop Med Hyg. 1999;93:35\u20139.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"445_CR39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/oxfordjournals.bmb.a011689","volume":"54","author":"RW Snow","year":"1998","unstructured":"Snow RW, Marsh K. New insights into the epidemiology of malaria relevant for disease control. Br Med Bull. 1998;54:293\u2013309.","journal-title":"Br Med Bull."},{"key":"445_CR40","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1086\/596741","volume":"199","author":"B Greenhouse","year":"2009","unstructured":"Greenhouse B, Slater M, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Clark TD, et al. Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. J Infect Dis. 2009;199:758\u201365.","journal-title":"J Infect Dis."},{"key":"445_CR41","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4269\/ajtmh.2001.65.614","volume":"65","author":"RN Price","year":"2001","unstructured":"Price RN, Simpson JA, Nosten F, Luxemburger C, Hkirjaroen L, ter Kuile F, et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg. 2001;65:614\u201322.","journal-title":"Am J Trop Med Hyg."},{"key":"445_CR42","doi-asserted-by":"publisher","first-page":"e110789","DOI":"10.1371\/journal.pone.0110789","volume":"9","author":"JR Matangila","year":"2014","unstructured":"Matangila JR, Doua JY, Linsuke S, Madinga J. Inoc\u00eancio Da Luz R, Van Geertruyden J-P, et al. Malaria, schistosomiasis and soil transmitted helminth burden and their correlation with anemia in children attending primary schools in Kinshasa. Democratic Republic of Congo. PLoS One. 2014;9:e110789.","journal-title":"PLoS One."},{"key":"445_CR43","unstructured":"WorldWide Antimalarial Resistance Network (WWARN): Haematology Study Group. [ http:\/\/www.wwarn.org\/working-together\/study-groups\/haematology-study-group ]"},{"key":"445_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00003088-199937020-00002","volume":"37","author":"NJ White","year":"1999","unstructured":"White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet. 1999;37:105\u201325.","journal-title":"Clin Pharmacokinet."},{"key":"445_CR45","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","volume":"44","author":"F Ezzet","year":"2000","unstructured":"Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000;44:697\u2013704.","journal-title":"Antimicrob Agents Chemother."},{"key":"445_CR46","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization (WHO)","year":"2010","unstructured":"World Health Organization (WHO). Guidelines for the treatment of malaria. 2nd ed. Geneva: WHO; 2010.","edition":"2"},{"key":"445_CR47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit079","author":"RN Price","year":"2013","unstructured":"Price RN. Potential of artemisinin-based combination therapies to block malaria transmission. J Infect Dis. 2013. doi: 10.1093\/infdis\/jit079 .","journal-title":"J Infect Dis"},{"key":"445_CR48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/S1473-3099(15)70024-1","volume":"15","author":"WorldWide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group","year":"2015","unstructured":"WorldWide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect Dis. 2015;15:692\u2013702.","journal-title":"Lancet Infect Dis"},{"key":"445_CR49","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/tmi.12309","volume":"19","author":"I Elliott","year":"2014","unstructured":"Elliott I, Mayxay M, Yeuichaixong S, Lee SJ, Newton PN. The practice and clinical implications of tablet splitting in international health. Trop Med Int Health. 2014;19:754\u20136.","journal-title":"Trop Med Int Health."},{"key":"445_CR50","doi-asserted-by":"publisher","first-page":"h602","DOI":"10.1136\/bmj.h602","volume":"350","author":"PN Newton","year":"2015","unstructured":"Newton PN, Schellenberg D, Ashley EA, Ravinetto R, Green MD, Kuile FOT, et al. Quality assurance of drugs used in clinical trials: proposal for adapting guidelines. BMJ. 2015;350:h602.","journal-title":"BMJ."},{"key":"445_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1475-2875-7-55","volume":"7","author":"D M\u00e9nard","year":"2008","unstructured":"M\u00e9nard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona L-P, Raharimalala L, Domarle O, et al. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J. 2008;7:55.","journal-title":"Malar J."},{"key":"445_CR52","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1475-2875-8-125","volume":"8","author":"JL Ndiaye","year":"2009","unstructured":"Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, et al. Randomized, multicentre assessment of the efficacy and safety of ASAQ - a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J. 2009;8:125.","journal-title":"Malar J."},{"key":"445_CR53","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1475-2875-7-16","volume":"7","author":"JL Ndiaye","year":"2008","unstructured":"Ndiaye JL, Faye B, Diouf AM, Kuete T, Cisse M, Seck PA, et al. Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria. Malar J. 2008;7:16.","journal-title":"Malar J."},{"key":"445_CR54","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","volume":"210","author":"R Tahar","year":"2014","unstructured":"Tahar R, Almelli T, Debue C, Foumane Ngane V, Djaman Allico J, Whegang Youdom S, et al. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. J Infect Dis. 2014;210:1962\u201371.","journal-title":"J Infect Dis."},{"key":"445_CR55","doi-asserted-by":"publisher","first-page":"e26005","DOI":"10.1371\/journal.pone.0026005","volume":"6","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Sasi P, Mwai L, Bashraheil M, Abdallah A, Muriithi S, et al. Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast. PLoS One. 2011;6:e26005.","journal-title":"PLoS One."},{"key":"445_CR56","doi-asserted-by":"crossref","unstructured":"Tabernero P, Fern\u00e1ndez FM, Green M, Guerin PJ, Newton PN. Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network database. Malar J. 2014;13:139.v","DOI":"10.1186\/1475-2875-13-139"},{"key":"445_CR57","doi-asserted-by":"publisher","first-page":"824","DOI":"10.4269\/ajtmh.12-0675","volume":"89","author":"SC Murphy","year":"2013","unstructured":"Murphy SC, Shott JP, Parikh S, Etter P, Prescott WR, Stewart VA. Malaria diagnostics in clinical trials. Am J Trop Med Hyg. 2013;89:824\u201339.","journal-title":"Am J Trop Med Hyg."},{"key":"445_CR58","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis."},{"key":"445_CR59","volume-title":"Methods manual. Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings","author":"Special Programme for Research and Training in Tropical Diseases (TDR)\/World Health Organization (WHO)","year":"2015","unstructured":"Special Programme for Research and Training in Tropical Diseases (TDR)\/World Health Organization (WHO). Methods manual. Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings. Geneva: WHO; 2015. [ http:\/\/www.who.int\/tdr\/publications\/microscopy_detec_ident_quantif\/en\/ ]"},{"key":"445_CR60","doi-asserted-by":"crossref","unstructured":"White LJ, Flegg JA, Phyo AP, Wiladpai-Ngern JH, Bethell D, Plowe C, et al. Defining the In vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach. PLoS Med. 2015;12:e1001823.","DOI":"10.1371\/journal.pmed.1001823"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-015-0445-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-015-0445-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T01:56:07Z","timestamp":1567130167000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-015-0445-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,7]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s12916-015-0445-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,7]]},"article-number":"212"}}